STOCK TITAN

Personalis to Announce First Quarter 2023 Financial Results

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary

Personalis, Inc. (NASDAQ: PSNL) has announced that it will release its first quarter 2023 financial results on May 3, 2023. A conference call and webcast will follow at 2:00 p.m. Pacific Time to discuss the financial outcomes and company milestones. Interested parties can access the call via phone or through the company's website. Personalis specializes in advanced genomics aimed at improving cancer management through personalized testing and highly sensitive assays.

Positive
  • None.
Negative
  • None.

FREMONT, Calif.--(BUSINESS WIRE)-- Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for precision oncology, announced today that it will release its first quarter 2023 financial results on Wednesday, May 3, 2023. In conjunction with the release, Personalis will host a conference call and webcast that day at 2:00 p.m. Pacific Time / 5:00 p.m. Eastern Time to discuss its financial results and recent highlights.

Interested parties may access the call by dialing 877-451-6152 for domestic callers or 201-389-0879 for international callers. The webinar of the call may be accessed by visiting the Events section of the company's website at investors.personalis.com. A replay of the webinar will be available shortly after the conclusion of the call and will be archived on the company's website.

About Personalis, Inc.

At Personalis, we are transforming the active management of cancer through breakthrough personalized testing. We aim to drive a new paradigm for cancer management, guiding care from biopsy through the life of the patient. Our highly sensitive assays combine tumor-and-normal profiling with proprietary algorithms to deliver advanced insights even as cancer evolves over time. Our products are designed to detect minimal residual disease (MRD) and recurrence at the earliest timepoints, enable selection of targeted therapies based on ultra-comprehensive genomic profiling, and enhance biomarker strategy for drug development. Personalis is based in Fremont, California. To learn more, visit www.personalis.com and connect with us on LinkedIn and Twitter.

Investor Relations Contact:

Caroline Corner

investors@personalis.com

415-202-5678

Media Contact:

Jennifer Temple

pr@personalis.com

www.personalis.com

650-752-1300

Source: Personalis, Inc.

FAQ

When will Personalis release its first quarter 2023 financial results?

Personalis will release its first quarter 2023 financial results on May 3, 2023.

What time is the Personalis Q1 2023 conference call?

The conference call for Personalis's Q1 2023 results is scheduled for 2:00 p.m. Pacific Time.

How can I access the Personalis conference call?

You can access the Personalis conference call by dialing 877-451-6152 for domestic calls or 201-389-0879 for international calls, or by visiting the company's website.

What is the focus of Personalis's business?

Personalis focuses on advanced genomics for precision oncology, providing personalized testing to improve cancer management.

Personalis, Inc.

NASDAQ:PSNL

PSNL Rankings

PSNL Latest News

PSNL Stock Data

474.58M
54.05M
19.3%
53.16%
4.04%
Diagnostics & Research
Services-medical Laboratories
Link
United States of America
FREMONT